Please use this identifier to cite or link to this item: https://doi.org/10.1007/s00894-009-0514-1
Title: Explaining the inhibition of cyclin-dependent kinase 5 by peptides derived from p25 with molecular dynamics simulations and MM-PBSA
Authors: Tan, V.B.C. 
Zhang, B. 
Lim, K.M. 
Tay, T.E. 
Keywords: Cyclin-dependent kinase
Energy decomposition
Inhibition
Molecular dynamics simulations
Issue Date: Jan-2010
Citation: Tan, V.B.C., Zhang, B., Lim, K.M., Tay, T.E. (2010-01). Explaining the inhibition of cyclin-dependent kinase 5 by peptides derived from p25 with molecular dynamics simulations and MM-PBSA. Journal of Molecular Modeling 16 (1) : 1-8. ScholarBank@NUS Repository. https://doi.org/10.1007/s00894-009-0514-1
Abstract: A cyclin-dependent kinase (CDK) 5 inhibitory peptide (CIP) from p25 was recently reported to inhibit CDK5/p25 activity in vitro but had no effect on endogenous cdc2 kinase activity. This may lead to a specific CDK5 inhibition strategy in the treatment of neurodegeneration. However, the mechanism of the inhibition remains unclear. In this work, molecular dynamics simulations and energy decomposition calculation models were set up to investigate the deregulation mechanisms of CIP on CDK5 activity. The results show that truncation of the N, and C terminals of p25 introduces important conformational changes into a hydrophobic pocket that is crucial for accommodating Ile153 on the activation loop of CDK5. In addition, such truncations lead to distortion and displacement of the activation loop and consequently affect binding of the substrate peptide. New inhibition sites for selectively inhibiting the activity of CDK5 are also suggested. © 2009 Springer-Verlag.
Source Title: Journal of Molecular Modeling
URI: http://scholarbank.nus.edu.sg/handle/10635/60264
ISSN: 16102940
DOI: 10.1007/s00894-009-0514-1
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.